Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 31:2023:6080489.
doi: 10.1155/2023/6080489. eCollection 2023.

Biofilm Formation and Phospholipase and Proteinase Production in Cryptococcus neoformans Clinical Isolates and Susceptibility towards Some Bioactive Natural Products

Affiliations

Biofilm Formation and Phospholipase and Proteinase Production in Cryptococcus neoformans Clinical Isolates and Susceptibility towards Some Bioactive Natural Products

Borel Ndezo Bisso et al. ScientificWorldJournal. .

Abstract

Background: Cryptococcosis is one of the most common fungal infections in immunocompromised patients, which is caused by Cryptococcus neoformans. However, relatively little is known about the virulence factors of C. neoformans and the incidence of antifungal drug resistance in C. neoformans is rapidly increasing. This study was undertaken to investigate the virulence factors in C. neoformans, thymol, curcumin, piperine, gallic acid, eugenol, and plumbagin for their potential antimicrobial activity against C. neoformans.

Methods: The production of phospholipase and proteinase was detected using standard methods. Biofilm formation was determined using the microtiter plate method. The broth microdilution method was used to determine the antifungal activity. The antibiofilm activity was assessed using the safranin staining method.

Results: All isolates of C. neoformans produced biofilms with optical density values ranging from 0.16 to 0.89. A majority of C. neoformans isolates that were tested exhibited strong phospholipase (7/8) and proteinase (5/8) production. Plumbagin (with minimum inhibitory concentration values ranging from 4 to 16 μg/mL) showed the highest antifungal activity followed by thymol (with minimum biofilm inhibitory concentration values ranging from 8 to 64 μg/mL). In addition, plumbagin showed the highest antibiofilm activity with minimum biofilm inhibitory concentration and minimum biofilm eradication concentration values ranging from 4 to 16 μg/mL and 32 to 256 μg/mL, respectively.

Conclusion: Plumbagin, compared to other natural products studied, was the most efficient in terms of antifungal and antibiofilm activities. Hence, plumbagin could be used in combination with antifungals for the development of new anticryptococcal drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Moosa M.-Y. S., Lessells R. J. Toward simpler, safer treatment of Cryptococcal Meningitis. New England Journal of Medicine . 2022;386(12):1179–1181. doi: 10.1056/nejme2201150. - DOI - PubMed
    1. Liu T. B., Perlin D. S., Xue C. Molecular mechanisms of cryptococcal meningitis. Virulence . 2012;3(2):173–181. doi: 10.4161/viru.18685. - DOI - PMC - PubMed
    1. Rajasingham R., Smith R. M., Park B. J., et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. The Lancet Infectious Diseases . 2017;17(8):873–881. doi: 10.1016/S1473-3099(17)30243-8. - DOI - PMC - PubMed
    1. Bisso B. N., Kayoka-Kabongo P. N., Tchuenguem R. T., Dzoyem J. P. Phytochemical analysis and antifungal potentiating activity of extracts from loquat (Eriobotrya japonica) against Cryptococcus neoformans clinical isolates. Advances in Pharmacological and Pharmaceutical Sciences . 2022;2022:6. doi: 10.1155/2022/6626834.6626834 - DOI - PMC - PubMed
    1. Qian W., Li X., Liu Q., Lu J., Wang T., Zhang Q. Antifungal and antibiofilm efficacy of paeonol treatment against biofilms comprising Candida albicans and/or Cryptococcus neoformans. Frontiers in Cellular and Infection Microbiology . 2022;12 doi: 10.3389/fcimb.2022.884793.884793 - DOI - PMC - PubMed

LinkOut - more resources